AbbVie Board Will Meet to Discuss Merger

The transcript discusses the impact of proposed Treasury Department rules on a major deal involving AbbVie. Initially, the deal seemed unaffected, but further analysis suggested significant implications, leading to a $1.6 billion breakup fee. The rules, though not finalized, have caused market speculation and affected hedge funds. Despite some deals proceeding, the rules have deterred others, highlighting the complexity and potential impact of these regulations.

What reasons were given for the boards' decisions to move forward with certain deals despite the new rules?

How did the proposed rules affect the perception of tax advantages in corporate mergers?